Jack Barkin joins Easton Pharmaceuticals as CMO
This article was originally published in Scrip
Easton Pharmaceuticals has appointed Dr Jack Barkin senior vice-president and chief medical officer. Dr Barkin is, among other things, a director of the Society of Urologic Surgeons of Ontario, vice-president of the Canadian Male Sexual Health Council and a member of numerous medical advisory boards for companies such as Pfizer, Eli Lilly, GSK, AstraZeneca, Sanofi and Merck.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.